open access

Vol 47, No 1 (2015)
Original and clinical articles
Submitted: 2015-03-06
Get Citation

Ventilator-associated pneumonia monitoring according to the INICC project at one centre

Wiesława Duszyńska, Victor D. Rosenthal, Barbara Dragan, Paulina Węgrzyn, Anna Mazur, Patrycja Wojtyra, Agnieszka Tomala, Andrzej Kübler
DOI: 10.5603/AIT.2015.0004
·
Anaesthesiol Intensive Ther 2015;47(1):34-39.

open access

Vol 47, No 1 (2015)
Original and clinical articles
Submitted: 2015-03-06

Abstract

BACKGROUND: Pneumonia is a common complication of hospitalisation in severely ill patients who need mechanical ventilation. The aim of this study was to assess the usefulness of the International Nosocomial Infection Control Consortium programme for the surveillance of ventilator-associated pneumonia (VAP).

METHODS: A prospective study (1 Jan 2012−30 June 2014) was conducted in the 20-bed ICU. The device utilisation ratios for lung ventilation and the frequency (density and incidence) and aetiology of VAP were estimated in ICU patients.

RESULTS: From a total of 1097 patients, VAP infections were diagnosed in 93. Thirty percent of patients with VAP died. The incidence index was 8.47 per 100 admissions to the ICU. VAP infections accounted for 46% of the overall count of device-associated healthcare-associated infections. Mechanical ventilation was used in 71 ± 8 patients during the 11 862 patient days and 8425 ventilation days. The rate of VAP per 1000 ventilator days was 11.15/9.34 /10.23 in years 2012/2013/2014 (half a year), respectively. The main VAP pathogens were Acinetobacter baumannii (45%) and Pseudomonas aeruginosa (17%).

CONCLUSION: During the reported time span, the incidence of VAP was lower than in the INICC report (2007–2012), but it was tenfold higher than in the NHSN/CDC report (dated 2012). Because of the unchanged VAP level during the 2.5-year observation period, the root cause needs to be determined and action should be taken to resolve this issue.

Abstract

BACKGROUND: Pneumonia is a common complication of hospitalisation in severely ill patients who need mechanical ventilation. The aim of this study was to assess the usefulness of the International Nosocomial Infection Control Consortium programme for the surveillance of ventilator-associated pneumonia (VAP).

METHODS: A prospective study (1 Jan 2012−30 June 2014) was conducted in the 20-bed ICU. The device utilisation ratios for lung ventilation and the frequency (density and incidence) and aetiology of VAP were estimated in ICU patients.

RESULTS: From a total of 1097 patients, VAP infections were diagnosed in 93. Thirty percent of patients with VAP died. The incidence index was 8.47 per 100 admissions to the ICU. VAP infections accounted for 46% of the overall count of device-associated healthcare-associated infections. Mechanical ventilation was used in 71 ± 8 patients during the 11 862 patient days and 8425 ventilation days. The rate of VAP per 1000 ventilator days was 11.15/9.34 /10.23 in years 2012/2013/2014 (half a year), respectively. The main VAP pathogens were Acinetobacter baumannii (45%) and Pseudomonas aeruginosa (17%).

CONCLUSION: During the reported time span, the incidence of VAP was lower than in the INICC report (2007–2012), but it was tenfold higher than in the NHSN/CDC report (dated 2012). Because of the unchanged VAP level during the 2.5-year observation period, the root cause needs to be determined and action should be taken to resolve this issue.

Get Citation

Keywords

hospital infections, ventilator-associated pneumonia

About this article
Title

Ventilator-associated pneumonia monitoring according to the INICC project at one centre

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 47, No 1 (2015)

Pages

34-39

DOI

10.5603/AIT.2015.0004

Bibliographic record

Anaesthesiol Intensive Ther 2015;47(1):34-39.

Keywords

hospital infections
ventilator-associated pneumonia

Authors

Wiesława Duszyńska
Victor D. Rosenthal
Barbara Dragan
Paulina Węgrzyn
Anna Mazur
Patrycja Wojtyra
Agnieszka Tomala
Andrzej Kübler

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl